Perrigo Total Assets 2006-2019 | PRGO

Perrigo total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Perrigo total assets for the quarter ending December 31, 2019 were $11.301B, a 2.9% increase year-over-year.
  • Perrigo total assets for 2019 were $11.301B, a 2.9% increase from 2018.
  • Perrigo total assets for 2018 were $10.983B, a 5.55% decline from 2017.
  • Perrigo total assets for 2017 were $11.629B, a 16.16% decline from 2016.
Perrigo Annual Total Assets
(Millions of US $)
2019 $11,301
2018 $10,983
2017 $11,629
2016 $13,870
2015 $19,350
2015 $19,592
2014 $13,853
2013 $5,351
2012 $4,024
2011 $3,189
2010 $3,109
2009 $2,443
2008 $2,578
2007 $1,925
2006 $1,751
2005 $1,705
Perrigo Quarterly Total Assets
(Millions of US $)
2019-12-31 $11,301
2019-09-30 $11,311
2019-06-30 $11,429
2019-03-31 $11,120
2018-12-31 $10,983
2018-09-30 $10,943
2018-06-30 $11,226
2018-03-31 $11,640
2017-12-31 $11,629
2017-09-30 $11,843
2017-06-30 $11,792
2017-03-31 $13,979
2016-12-31 $13,870
2016-09-30 $15,888
2016-06-30 $18,291
2016-03-31 $19,500
2015-12-31 $19,350
2015-09-30 $19,703
2015-06-30 $19,721
2015-03-31 $16,183
2014-12-31 $16,461
2014-09-30 $13,781
2014-06-30 $13,880
2014-03-31 $13,743
2013-12-31 $13,713
2013-09-30 $5,509
2013-06-30 $5,351
2013-03-31 $4,496
2012-12-31 $4,294
2012-09-30 $4,117
2012-06-30 $4,024
2012-03-31 $4,040
2011-12-31 $3,943
2011-09-30 $3,514
2011-06-30 $3,189
2011-03-31 $3,037
2010-12-31 $2,935
2010-09-30 $2,772
2010-06-30 $3,109
2010-03-31 $2,489
2009-12-31 $2,459
2009-09-30 $2,407
2009-06-30 $2,536
2009-03-31 $2,372
2008-12-31 $2,428
2008-09-30 $2,505
2008-06-30 $2,581
2008-03-31 $2,199
2007-12-31 $2,039
2007-09-30 $1,947
2007-06-30 $1,925
2007-03-31 $1,891
2006-12-31 $1,854
2006-09-30 $1,816
2006-06-30 $1,751
2006-03-31 $1,671
2005-12-31 $1,684
2005-09-30 $1,691
2005-06-30 $1,705
2005-03-31 $1,731
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $6.476B $4.837B
Perrigo Company plc develops, manufactures and distributes healthcare products. The company operates primarily in four segments: Consumer Healthcare, Nutritionals, Rx Pharmaceutical and Active Pharmaceutical Ingredients. It also provides animal health products. The company operates primarily in the United States, the United Kingdom, Mexico, Israel, Australia, Canada, China and Latin America. Perrigo Company plc formerly known as Perrigo Company is headquartered in Ireland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $145.889B 25.53
Medtronic (MDT) Ireland $126.096B 16.95
Stryker (SYK) United States $62.094B 20.06
Boston Scientific (BSX) United States $45.907B 20.68
Baxter (BAX) United States $43.082B 26.29
Coloplast (CLPBY) Denmark $31.666B 48.87
Lonza Group Ag (LZAGY) Switzerland $30.808B 0.00
Terumo (TRUMY) Japan $25.125B 0.00
EssilorLuxottica Societe Anonyme (ESLOY) France $24.988B 0.00
ResMed (RMD) United States $22.893B 39.77
Zimmer Biomet Holdings (ZBH) United States $20.215B 12.44
Smith & Nephew SNATS (SNN) United Kingdom $15.935B 0.00
Sunny Optical Technology (SNPTF) China $14.665B 0.00
Bio-Rad Laboratories (BIO) United States $11.410B 53.33
Insulet (PODD) United States $10.806B 661.15
William Demant Holdings (WILYY) Denmark $7.898B 0.00
Hill-Rom Holdings (HRC) United States $7.302B 21.00
DiaSorin S.p.A (DSRLF) Italy $6.994B 0.00
GN STORE NORD (GNNDY) Denmark $6.057B 31.29
Haemonetics (HAE) United States $5.142B 31.65
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
Canopy Growth (CGC) Canada $5.010B 0.00
ICU Medical (ICUI) United States $4.301B 28.09
Quidel (QDEL) United States $4.034B 35.41
Neogen (NEOG) United States $3.598B 60.95
Agios Pharmaceuticals (AGIO) United States $2.706B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.677B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.438B 0.00
NuVasive (NUVA) United States $2.419B 18.71
Envista Holdings (NVST) United States $2.275B 0.00
National Vision Holdings (EYE) United States $1.476B 24.86
AtriCure (ATRC) United States $1.368B 0.00
Cardiovascular Systems (CSII) United States $1.302B 0.00
TG Therapeutics (TGTX) United States $1.046B 0.00
Phibro Animal Health (PAHC) United States $0.986B 19.50
Aurora Cannabis (ACB) Canada $0.973B 0.00
NanoString Technologies (NSTG) United States $0.921B 0.00
VAREX IMAGING (VREX) United States $0.835B 17.34
Aphria (APHA) $0.802B 0.00
Cerus (CERS) United States $0.788B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.757B 136.15
Omeros (OMER) United States $0.752B 0.00
InMode (INMD) Israel $0.709B 0.00
OraSure Technologies (OSUR) United States $0.689B 85.46
PetIQ (PETQ) United States $0.675B 18.38
Eagle Pharmaceuticals (EGRX) United States $0.647B 38.48
Quanterix (QTRX) United States $0.596B 0.00
LeMaitre Vascular (LMAT) United States $0.490B 27.59
Surmodics (SRDX) United States $0.455B 52.30
Lantheus Holdings (LNTH) United States $0.440B 9.90
Owens & Minor (OMI) United States $0.427B 11.67
Meridian Bioscience (VIVO) United States $0.380B 15.31
Zynex (ZYXI) United States $0.371B 39.96
Vapotherm (VAPO) United States $0.367B 0.00
Repro-Med Systems (KRMD) United States $0.337B 212.50
Utah Medical Products (UTMD) United States $0.305B 21.83
Organigram Holdings (OGI) Canada $0.296B 0.00
MacroGenics (MGNX) United States $0.273B 0.00
Cytosorbents (CTSO) United States $0.220B 0.00
BioLife Solutions (BLFS) United States $0.210B 128.63
Female Health (VERU) United States $0.203B 0.00
HEXO (HEXO) $0.197B 0.00
InfuSystems Holdings (INFU) United States $0.191B 159.67
Exagen (XGN) United States $0.170B 0.00
Viemed Healthcare (VMD) United States $0.169B 19.13
Rockwell Medical (RMTI) United States $0.144B 0.00
United Health Products (UEEC) United States $0.140B 0.00
Evolus (EOLS) United States $0.131B 0.00
Bovie Medical (APYX) United States $0.127B 0.00
Liberty Health Sciences (LHSIF) Canada $0.111B 0.00
Chembio Diagnostics (CEMI) United States $0.110B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.107B 0.00
Fonar (FONR) United States $0.097B 7.08
Chimerix (CMRX) United States $0.086B 0.00
Brainsway (BWAY) Israel $0.082B 0.00
MTech Acquisition (KERN) United States $0.079B 0.00
United-Guardian (UG) United States $0.063B 13.17
Green Organic Dutchman Holdings (TGODF) Canada $0.062B 0.00
Nephros (NEPH) United States $0.060B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.055B 0.00
Wound Management Technologies (SMTI) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.049B 0.00
GUARDION HEALTH (GHSI) United States $0.036B 0.00
ImmuCell (ICCC) United States $0.029B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.024B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Myomo (MYO) United States $0.010B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
NeuroMetrix (NURO) United States $0.002B 0.00